Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2005
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example
09/15/2005US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs
09/15/2005US20050203071 Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
09/15/2005US20050203068 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/15/2005US20050203066 Preventing mitochondrial respiratory chain dysfunction in mammal by administering a pyrimidine nucleotide precursor and pyruvic acid, ester or salt; neurodegenerative, muscular, urogenital, or developmental disorders; autism, neuropathic pain, headaches; anticarcinogenic agents; cognition activators
09/15/2005US20050203062 Use of tagatose in laxatives
09/15/2005US20050203003 Contulakin-G, analogs thereof and uses therefor
09/15/2005US20050202462 Hepatic modulator for prevention and treatment of hepatic dysfunction, hepatitis and liver cancer
09/15/2005US20050202107 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201980 Method for short-term and long-term drug dosimetry
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2557976A1 Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
09/15/2005CA2557634A1 Stable capsule preparation
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574519A1 Transcription control factor ZHX3
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1574512A1 Polymorphic and other crystalline forms of cis-FTC
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574207A1 Cosmetic use of viscous compositions containing carbon dioxide
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572742A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
09/14/2005EP1572692A1 Enantiomer (-) of tenatoprazole and the therapeutic use thereof
09/14/2005EP1572684A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572680A2 Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572641A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers
09/14/2005EP1572240A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors
09/14/2005EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
09/14/2005EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572182A1 Composition for the treatment of gastrointestinal disorders
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572151A1 Liquid dosage forms of proton pump inhibitors
09/14/2005EP1572149A2 Immunogenicity of glucan binding protein
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1401432B1 Imidazole derivatives for modulating sodium channels
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668734A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/14/2005CN1668319A Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/14/2005CN1668314A Methods of treating hepatitis
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668307A New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2, 3-d]pyrimidine
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668295A Medicinal composition
09/14/2005CN1668294A Use of nefopam for the treatment of nausea or emesis
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
09/14/2005CN1668212A Compositions comprising lactoferrin
09/14/2005CN1667120A RNA interfered target sequence of HBV and use thereof
09/14/2005CN1666994A Zinc bismuth glycyrrhetate (compound) and preparation method thereof
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1666773A Pharmaceutical composition for preventing and/or treating oral disease caused by microbe
09/14/2005CN1666772A Intelligence-developing, heart-nourishing, mind-tranquilizing and digestion-aiding oral liquid
09/14/2005CN1666770A Chinese medicine for treating liver cancer and ascites caused thereby
09/14/2005CN1666767A Pharmaceutical composition for treating gastritis and stomach ulcer and preparation method thereof
1 ... 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 ... 1258